Literature DB >> 265135

Hemoglobin A2 levels in health and various hematologic disorders.

J B Alperin, P A Dow, M B Petteway.   

Abstract

Using a method involving elution of hemoglobin bands from cellulose acetate strips following electrophoresis of hemolysates, hemoglobin A2 (Ab A2) was quantitated in bloods from 300 healthy individuals and 904 patients. The percentage of Hb A2 was elevated in beta-thalassemia heterozygotes and some patients who had megaloblastic anemia. In the latter, the highest Hb A2 levels were observed in patients with the most severe anemia. Low Hb A2 percentages were found in iron-deficiency anemia, hereditary persistance of fetal hemoglobin, and Hb H disease. In iron-deficiency anemia, the lowest levels of Hb A2 were observed in association with the most severe anemia. Iron and folate deficiency each suppressed Hb A2 levels in beta-thalassemia heterozygotes; however, vitamin B12 deficiency did not alter the percentage of Hb A2 in thalassemia. Malignant tumors, renal and hepatic insufficiency, chronic infections and inflammation, hemolytic disease, lead poisoning, aplastic anemia, leukemia, myelofibrosis, and hypothyroidism did not change Hb A2 levels. The pathogenesis of altered Hb A2 levels and their clinical significance in various diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 265135     DOI: 10.1093/ajcp/67.3.219

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  Iron deficiency does not compromise the diagnosis of high HbA(2) β thalassemia trait.

Authors:  Cristina Passarello; Antonino Giambona; Monica Cannata; Margherita Vinciguerra; Disma Renda; Aurelio Maggio
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

2.  Filipino beta zero thalassaemia: a high Hb A2 beta zero thalassaemia resulting from a large deletion of the 5' beta globin gene region.

Authors:  P I Motum; A Kearney; T J Hamilton; R J Trent
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

3.  Guidelines for investigation of the alpha and beta thalassaemia traits. The Thalassaemia Working Party of the BCSH General Haematology Task Force.

Authors: 
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

4.  Diagnosis of Beta-thalassaemia carriers in the sultanate of oman.

Authors:  Shahina Daar; David Gravell
Journal:  Sultan Qaboos Univ Med J       Date:  2006-06

5.  Hemoglobin E and Glucose-6-Phosphate Dehydrogenase Deficiency and Plasmodium falciparum Malaria in the Chittagong Hill Districts of Bangladesh.

Authors:  Kerry L Shannon; Sabeena Ahmed; Hafizur Rahman; Chai S Prue; Jacob Khyang; Malathi Ram; M Zahirul Haq; Ashish Chowdhury; Jasmin Akter; Gregory E Glass; Timothy Shields; Myaing M Nyunt; Wasif A Khan; David A Sack; David J Sullivan
Journal:  Am J Trop Med Hyg       Date:  2015-06-22       Impact factor: 2.345

6.  Haemoglobin A2 levels in vitamin B12 and folate deficiency.

Authors:  L A Henshaw; J L Tizzard; K Booth; M E Beard
Journal:  J Clin Pathol       Date:  1978-10       Impact factor: 3.411

Review 7.  Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.

Authors:  Meric A Altinoz; Emin M Ozcan; Bahri Ince; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2016-05-28       Impact factor: 3.584

8.  Spectrum of haemoglobinopathies diagnosed by cation exchange-HPLC & modulating effects of nutritional deficiency anaemias from north India.

Authors:  Seema Rao; Rakhee Kar; Sanjeev Kumar Gupta; Anita Chopra; Renu Saxena
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

9.  Coexisting iron deficiency anemia and Beta thalassemia trait: effect of iron therapy on red cell parameters and hemoglobin subtypes.

Authors:  Sarika Verma; Ruchika Gupta; Madhur Kudesia; Alka Mathur; Gopal Krishan; Sompal Singh
Journal:  ISRN Hematol       Date:  2014-03-12

10.  Guidelines for the diagnosis of the haemoglobinopathies in Nigeria.

Authors:  Taiwo R Kotila
Journal:  Ann Ib Postgrad Med       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.